A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration

Particle and Fibre Toxicology

Gary J. Weil³  Mirani V. Weerasooriya¹  Prasad H. Premaratne²  Melanie M. Lloyd³  Peter U. Fischer³  Femmy Pical⁴  Difa Stefani⁴  Yenny Djuardi⁴  Ramakrishna U. Rao³  Taniawati Supali⁴  Thishan C. Yahathugoda¹ 

[1] Filariasis Research, Training and Service Unit, Department of Parasitology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka;Department of Para Clinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate, Ratmalana, Sri Lanka;Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, MO, USA;Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia

关键词: Indonesia;    Sri Lanka;    Mass drug administration;    Elimination;    Antigenemia;    Diagnosis;    Wuchereria bancrofti;    Lymphatic filariasis;   

Others  :  1222229
DOI  :  10.1186/s13071-015-0979-y

 received in 2015-05-18, accepted in 2015-07-01,  发布年份 2015

【 摘 要 】

Background

Filarial antigen tests are key tools for mapping the distribution of bancroftian filariasis and for detecting areas with persistent infections following mass drug administration (MDA). A recent study showed that the new Alere Filariasis Test Strip (FTS) has better analytical sensitivity than the BinaxNOW Filariasis card test (Card Test) for detecting circulating filarial antigen, and the FTS detected more positive results than the Card Test in a field study performed in a highly endemic area in Liberia.

Methods

The present study compared the performance of the FTS and the Card Test in community surveys that were conducted in southern Sri Lanka and in Indonesia (Central Java) in areas with low-level persistence of LF following multiple rounds of MDA with diethylcarbamazine plus albendazole. The studies were performed in densely populated semi-urban areas where Wuchereria bancrofti is transmitted by Culex quinquefasciatus.

Results

Antigenemia rates by FTS were 138 % higher in the Sri Lanka study (43/852 vs. 18/852) and 21 % higher in the Indonesia study (50/778 vs. 41/778) than antigenemia rates by Card Test. Antigenemia rates were significantly higher in males than in females and higher in adults than in children in both study sites. Although overall antigenemia rates and test scores were significantly higher by FTS than by Card Test in both study areas, rates in young children were similar with both tests in both areas.

Conclusions

These results extend the previously reported superior sensitivity of the FTS to areas with low residual infection rates following MDA, and this could affect mapping and post-MDA survey results in adults. However, our findings suggest that results of transmission assessment surveys (TAS) performed in school-aged children are likely to be similar with both tests.

【 授权许可】

   
2015 Yahathugoda et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Lymphatic Filariasis. Progress Report 2000–2009 and Strategic Plan 2010–2020. WHO/HTM/NTD/PCT/20106). World Health Organization, Geneva; 2010.
• [2]Global programme to eliminate lymphatic filariasis: progress report. Wkly Epidemiol Rec / Health Section Secretariat League Nations 2014. 2013; 89(38):409-18.
• [3]Weil GJ, Ramzy RM. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 2007; 23(2):78-82.
• [4]Gass K, de Rochars MV B, Boakye D, Bradley M, Fischer PU, Gyapong J, Itoh M et al.. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis. 2012; 6(1): Article ID e1479
• [5]Preparing and implementing a national plan to eliminate lymphatic filariasis (in countries where onchocerciasis is not co-endemic). World Health Organization, Geneva; 2000.
• [6]Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level WHO/CDS/CPE/CEE/200550. World Health Organization, Geneva; 2005.
• [7]Monitoring and epidemiological assessment of mass drug administration in the Global Programme to Eliminate Lymphatic Filariasis: A manual for national elimination programmes. . WHO, (WHO/HTM/NTD/PCT/2011 4). World Health Organization, Geneva; 2011.
• [8]Rao RU, Nagodavithana KC, Samarasekera SD, Wijegunawardana AD, Premakumara WD, Perera SN et al.. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration. PLoS Negl Trop Dis. 2014; 8(11): Article ID e3281
• [9]Rebollo MP, Mohammed KA, Thomas B, Ame S, Ali SM, Cano J et al.. Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted? PLoS Negl Trop Dis. 2015; 9(3): Article ID e0003669
• [10]Weil GJ, Lammie PJ, Weiss N. The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997; 13(10):401-4.
• [11]Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ et al.. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. AmJTrop Med Hyg. 2013; 89(1):11-5.
• [12]WHO. Neglected tropical diseases. PCT data bank. http://www. who.int/neglected_diseases/preventive_chemotherapy/lf/en/ webcite
• [13]Yahathugoda TC, Weerasooriya M, Samarawickrema WA. An independent evaluation of the programme for the elimination of lymphatic filariasis. Galle Medical Journal. 2013; 18:31-43.
• [14]Desowitz RS, Hitchcock JC. Hyperendemic bancroftian filariasis in the Kingdom of Tonga: the application of the membrane filter concentration technique to an age-stratified blood survey. AmJTrop Med Hyg. 1974; 23(5):877-9.
• [15]R Core Team. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2014.